Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
The Fondation Innovative Medicines for Tuberculosis (iM4TB) is a non-profit organization based at EPFL dedicated to developing better and faster-acting medicines to combat all forms of tuberculosis. With a team of experienced researchers, iM4TB focuses on finding new molecules that can effectively kill the TB bacterium without harming patients. The foundation has received significant funding, including a grant from the Bill & Melinda Gates Foundation, to support the development of their innovative anti-tuberculosis drug PBTZ169. iM4TB's mission is crucial in the global fight against tuberculosis, a disease that claims the lives of three individuals every minute worldwide.